[go: up one dir, main page]

MX2021015830A - Formulaciones penetrantes transdermicas. - Google Patents

Formulaciones penetrantes transdermicas.

Info

Publication number
MX2021015830A
MX2021015830A MX2021015830A MX2021015830A MX2021015830A MX 2021015830 A MX2021015830 A MX 2021015830A MX 2021015830 A MX2021015830 A MX 2021015830A MX 2021015830 A MX2021015830 A MX 2021015830A MX 2021015830 A MX2021015830 A MX 2021015830A
Authority
MX
Mexico
Prior art keywords
transdermal delivery
transdermal
formulation
formulations
transdermal penetrant
Prior art date
Application number
MX2021015830A
Other languages
English (en)
Inventor
Nathan Fitzsimmons
Ryan Beal
Brandon Sand
Original Assignee
Dyve Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dyve Biosciences Inc filed Critical Dyve Biosciences Inc
Publication of MX2021015830A publication Critical patent/MX2021015830A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se divulga en la presente una formulación de suministro transdérmico para suministro transdérmicode un agente activo a través de la piel, uña o folículo capilar de un sujeto, en donde la formulación comprende a) una formulación de suministro transdérmico en una cantidad menor que aproximadamente 60 % p/p, que comprende i. uno o más fosfátidos, ii. glucosa, y iii. uno o más ácidos grasos; y b) agua en una cantidad menor que aproximadamente 50 % p/p.
MX2021015830A 2019-06-18 2020-06-18 Formulaciones penetrantes transdermicas. MX2021015830A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962863242P 2019-06-18 2019-06-18
PCT/US2020/038558 WO2020257537A1 (en) 2019-06-18 2020-06-18 Transdermal penetrant formulations

Publications (1)

Publication Number Publication Date
MX2021015830A true MX2021015830A (es) 2022-04-11

Family

ID=74040682

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021015830A MX2021015830A (es) 2019-06-18 2020-06-18 Formulaciones penetrantes transdermicas.

Country Status (12)

Country Link
US (1) US20220105062A1 (es)
EP (1) EP3986464A4 (es)
JP (1) JP2022537711A (es)
KR (1) KR20220054284A (es)
CN (1) CN115379859A (es)
AU (1) AU2020298248A1 (es)
BR (1) BR112021025545A2 (es)
CA (1) CA3144006A1 (es)
IL (1) IL289047A (es)
MA (1) MA56543A (es)
MX (1) MX2021015830A (es)
WO (1) WO2020257537A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220202844A1 (en) * 2020-12-31 2022-06-30 Richard Clark Kaufman Drug delivery composition and a method of administering the drug
WO2022155341A1 (en) * 2021-01-13 2022-07-21 Dyve Biosciences, Inc. Transdermal formulations for phosphodiesterase-5 inhibitors
CN115379837A (zh) * 2021-01-13 2022-11-22 黛芙生物科学公司 用于药物施用的透皮渗透制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4045097A (en) * 1996-07-23 1998-02-10 Wilson T. Crandall Transdermal transport of molecules
US20110052738A1 (en) * 2008-01-17 2011-03-03 Gary Dean Bennett Topical pain formulation
KR101781814B1 (ko) * 2009-10-26 2017-09-26 닛산 가가쿠 고교 가부시키 가이샤 화장료 및 피부외용제, 그리고 의료용 기기
RU2671857C1 (ru) * 2014-10-30 2018-11-07 Дельта-Флай Фарма, Инк. Новый способ производства липоплекса для местного введения и противоопухолевое средство, в котором используется такой липоплекс
EP3236903B1 (en) * 2014-12-23 2021-04-21 Intellectual Property Associates, LLC Methods and formulations for transdermal administration
WO2017127834A1 (en) * 2016-01-23 2017-07-27 Sand Bruce J Enhanced transdermal delivery of active agents
EP3435978A4 (en) * 2016-03-31 2019-12-11 Smartech Topical, Inc. RELEASE SYSTEM
EP3681479B1 (en) * 2017-09-15 2024-01-31 Dyve Biosciences, Inc. Sodium bicarbonate for use in the treatment of gout and related disorders
JP2022504310A (ja) * 2018-10-05 2022-01-13 アンパサンド バイオファーマシューティカルズ インコーポレイテッド 局所投与のための鉄製剤および鉄欠乏症の処置の方法
WO2020073033A1 (en) * 2018-10-05 2020-04-09 Ampersand Biopharmaceuticals, Inc. Formulations and methods for transdermal administration of ketones
US20210386906A1 (en) * 2018-10-23 2021-12-16 Dyve Biosciences, Inc. Methods and formulations for transdermal administration of dermal contouring agents

Also Published As

Publication number Publication date
EP3986464A4 (en) 2023-07-05
CN115379859A (zh) 2022-11-22
JP2022537711A (ja) 2022-08-29
BR112021025545A2 (pt) 2022-02-22
WO2020257537A1 (en) 2020-12-24
US20220105062A1 (en) 2022-04-07
AU2020298248A1 (en) 2022-02-03
IL289047A (en) 2022-02-01
MA56543A (fr) 2022-04-27
EP3986464A1 (en) 2022-04-27
CA3144006A1 (en) 2020-12-24
KR20220054284A (ko) 2022-05-02

Similar Documents

Publication Publication Date Title
MX2021015830A (es) Formulaciones penetrantes transdermicas.
CN106176270B (zh) 一种温和的氨基酸洗发水及其制备方法
US8147815B2 (en) Topical administration carrier composition and therapeutic formulations comprising same
AR052192A1 (es) Composiciones de microemulsion libre de alcohol
AR019997A1 (es) Sistema de administracion topica para agentes activos
TW200735897A (en) HFSH aqueous formulation
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
WO2009015913A3 (de) Naturkosmetisches haarbehandlungsmittel
KR19980081705A (ko) 안정하게 용해된 요산 및 수용성 중합체를 함유하는 수성 화장품 조성물 및 수성 화장품 조성물중에 요산을 안정하게 용해시키는 방법
TW200509981A (en) Sunscreen wipes having high sunscreen formulation transfer rate
NZ743161A (en) Pet care cleansing composition
DK1313511T3 (da) Testosteronesterformulering til human brug
PH12018500910A1 (en) Novel method of use and compositions
JP2014208714A (ja) 毛穴を閉塞する皮脂硬化物の溶解能を有する養毛剤
BR112022011909A2 (pt) Compostos de ácido graxo poliméricos não iônicos para o tratamento de substratos à base de aminoácidos fibrosos, especialmente cabelos
KR101937072B1 (ko) 다한증 치료용 외용제
ES2137125B1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
KR102164151B1 (ko) 육모제 조성물
PH12021551691A1 (en) Formulations containing active oxygen compounds and devices for application thereof
CO2023011644A2 (es) Composición antitranspirante
CU22866A3 (es) Formulación farmacéutica semisólida que contiene dexcetoprofentrometamol y procedimiento de obtención
MX2020010498A (es) Composiciones para el cuidado de la piel y sus aplicaciones.
JP2016102102A (ja) システアミンフリーベースを含むパーマ剤組成物｛Ａｐｅｒｍｃｏｍｐｏｓｉｔｉｏｎｃｏｍｐｒｉｓｉｎｇｃｙｓｔｅａｍｉｎｅｆｒｅｅｂａｓｅ｝
FR3068217B1 (fr) Agent de conservation comprenant de la 4-(3-ethoxy-4-hydroxyphenyl)-2-butanone, et son utilisation dans des compositions cosmetiques
US6528072B1 (en) Topical composition for skin including witch hazel